Efficacy and Safety Study of ABP 980 Compared With Trastuzumab in Women With HER2-positive Early Breast Cancer
Clinical trial NCT01901146 · COMPLETED
Trial details
- NCT number
- NCT01901146
- Sponsor
- Amgen
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-04-29
- Primary completion
- 2016-05-05
- Enrollment
- 725
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.